TCRT
TCRT
NASDAQ · Biotechnology

Alaunos Therapeutics Inc

$2.82
-0.16 (-5.37%)
As of Mar 30, 10:13 PM ET ·
Financial Highlights (FY 2026)
Revenue
13.1K
Net Income
-6,154,786
Gross Margin
Profit Margin
-46,790.0%
Rev Growth
-70.7%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 33.9% 33.9%
Operating Margin -48,120.0% -43,308.7% -6.9% -6.6%
Profit Margin -46,790.0% -44,450.5% -6.2% -6.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 13.1K 44.6K 1.35M 1.27M
Gross Profit 457.7K 431.9K
Operating Income -6,283,509 -19,307,470 -93,195 -83,844
Net Income -6,154,786 -18,911,940 -84,207 -82,182
Gross Margin 33.9% 33.9%
Operating Margin -48,120.0% -43,308.7% -6.9% -6.6%
Profit Margin -46,790.0% -44,450.5% -6.2% -6.5%
Rev Growth -70.7% -70.7% +20.4% +2.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 2.88M 2.33M
Total Equity 1.84M 1.81M
D/E Ratio 1.56 1.28
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -6,152,048 -19,953,723 -111,401 -119,566
Free Cash Flow -113,905 -126,135